In this retrospective analysis, we analyzed all clinical record data in our Medical Division between January 2005 and December 2006 to evaluate an association between clomipramine treatment and glucose intolerance. Of 1997 patients, 154 (7.7%) had diabetes and 525 (26.3%) had depression. Diabetes prevalence was significantly higher in patients treated with clomipramine than in patients not treated [odds ratio 3.9, (2.2-7.0), p < 0.00001], independently by age and BMI. A possible causal role needs to be investigated in a prospective way.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00592-013-0500-z | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!